Nr.NumelestudiuluiStatusLocatia/Locatiilestudiului
1Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin’s Lymphoma (iNHL) (CHRONOS-4)                                            Activ, nu se recruteazaSp. Judetean de Urgenta Dr. Constantin Opris Baia Mare, Baia Mare, Romania, 430031S.C. Policlinica de Diagnostic Rapid S.A., Brasov, Romania, 500152Fundeni Clinical Institute, Bucharest, Romania, 022328Spitalul Clinic Coltea, Bucharest, Romania, 030171Sp. Univ. de Urgenta Militar Central Dr. Carol Davila, Bucuresti, Romania, 010825Spitalul Clinic Colentina, Bucuresti, Romania, 020125Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca, Romania, 400124Spitalul Clinic Municipal Filantropia Craiova, Craiova, Romania, 200143Institutul Regional de Oncologie Iasi, Iasi, Romania, 700111Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu, Romania, 550245Spitalul Clinic Judetean de Urgenta Targu-Mures, Targu-Mures, Romania, 540136
2Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin’s Lymphoma (iNHL) (CHRONOS-3)Activ, inca nu se recruteazaBrasov, Romania, 500152Bucharest, Romania, 030171Bucuresti, Romania, 010825Bucuresti, Romania, 020125Bucuresti, Romania, 022328Cluj-Napoca, Romania, 400015Craiova, Romania, 200143Targu-Mures, Romania, 540136
3A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma  Activ, inca nu se recruteazaInstitut Clinic Fundeni, Bucuresti, Romania, 22328Spitalul Clinic de Urgenta pentru Copii M.S. Curie, Bucuresti, Romania, 41451Institutul Oncologic ‘Prof Dr. Ion Chiricuta’ Cluj-Napoca , Cluj-Napoca, Romania, 400015Spitalul Clinic Municipal Dr. Gavril Curteanu Oradea, Oradea, RomaniaSpitalul Clinic de Urgenta pentru Copii ‘Louis Turcanu’, Timisoara, Romania, 300011
4Dose Optimization Study of Idelalisib in Follicular LymphomaIn curs de recrutareSpitalul Judetean de Urgenta Dr.Constantin Opris Baia Mare, Baia Mare, RomaniaSpitalul Clinic Coltea, Bucuresti, RomaniaInstitutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca, Cluj-Napoca, RomaniaInstitutul Regional De Oncologie IASI, Iasi, Romania
5ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas (ECHELON-2)Activ, inca nu se recruteazaInstitutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu, Bucharest, Romania, 022328Spitalul Clinic Coltea, Bucuresti, Romania, 030171Institutul Oncologic „Prof. Dr. I. Chiricuta” Cluj-Napoca, Cluj-Napoca, Romania, 400015Spitalul Clinic Judetean de Urgenta Targu Mures, Sectia Clinica Hematologie si Transplant Medular, Targu Mures, Romania, 540136
6Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell LymphomaActiv, inca nu se recruteazaPoliclinica de Diagnostic Rapid SA, Brasov, Romania, 500152Spitalul Clinic Colentina, Bucuresti, Romania, 020125Spitalul Clinic Coltea, Bucuresti, Romania, 030171Spitalul Clinic Judetean de Urgenta Targu Mures, Targu Mures, Romania, 540042
7A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (B-MIND)In curs de recrutareMorphoSys Research Site, Bucharest, Romania, 022328MorphoSys Research Site, Bucharest, Romania, 30171MorphoSys Research Site, Iaşi, Romania, 700483
8Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.In curs de recrutareCluj NapocaIon Chiricuta Oncology Institute, Cluj Napoca, Romania, 400015 Contact: Ciprian Tomuleasa, MD    0040741337480    ciprian.tomuleasa@umfcluj.ro   Contact: Catalin Vlad, MD    0040264598362    catalinvlad@yahoo.it  
(Visited 6 times, 1 visits today)